MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer

NEW YORK -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the appointment of Stephanie Fagan, effective today, as Chief Corporate Affairs Officer. Ms. Fagan will serve as a member of the executive team and will oversee public affairs and corporate communications for the Company. Read More

MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer

MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer

MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer

MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer

MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer